BackLiquidia Overview
Liquidia Corp

Liquidia P/E Ratio

Valuation check: LQDA's P/E ratio is 43.14, above the Healthcare sector average of 25.9.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

43.14

P/E Ratio

43.14

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Liquidia (LQDA) FAQ

Liquidia's p/e ratio stands at 43.14. That is above the Healthcare sector average of 25.9. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Liquidia sits higher the Healthcare benchmark (25.9) with a P/E ratio of 43.14. That is roughly 66.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 43.14 is attractive depends on Liquidia's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Liquidia's P/E ratio evolved across reporting periods, while the comparison chart places LQDA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Liquidia's reading of 43.14 (sector avg 25.9) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.